Last update 01 Nov 2024

Beijing Danqing Pharmaceutical Technology Co., Ltd.

Private Company|
2021|
Beijing Shi, China
|
www.danatlas.com

Overview

Tags

Neoplasms
Urogenital Diseases
Digestive System Disorders
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms5
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug5
Top 5 TargetCount
PARG(Poly(ADP-ribose) glycohydrolase)2
WRN(WRN RecQ like helicase)1
POLQ(DNA polymerase theta)1

Related

8
Drugs associated with Beijing Danqing Pharmaceutical Technology Co., Ltd.
DAT-2645
Target
PARG
Mechanism
PARG inhibitors
Active Org.
Beijing Danqing Pharmaceutical Technology Co., Ltd.
Originator Org.
Beijing Danqing Pharmaceutical Technology Co., Ltd.
Active Indication
Advanced cancer [+9]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
DAT-2000
Target
PARG
Mechanism
PARG inhibitors
Active Org.
Beijing Danqing Pharmaceutical Technology Co., Ltd.
Originator Org.
Beijing Danqing Pharmaceutical Technology Co., Ltd.
Active Indication
Solid tumor [+1]
Inactive Indication
Gastrointestinal Neoplasms
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
DAT-5000
Target
WRN
Mechanism
WRN inhibitors
Active Org.
Beijing Danqing Pharmaceutical Technology Co., Ltd.
Originator Org.
Beijing Danqing Pharmaceutical Technology Co., Ltd.
Active Indication
Solid tumor [+2]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Beijing Danqing Pharmaceutical Technology Co., Ltd.
NCT06614751 / Not yet recruitingPhase 1
A Phase I, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of DAT-2645 in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DNA Damage Repair Pathway
100 Clinical Results associated with Beijing Danqing Pharmaceutical Technology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Beijing Danqing Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Deals associated with Beijing Danqing Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Beijing Danqing Pharmaceutical Technology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
2
Phase 1 Clinical
Other
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
DAT-2000
 ( PARG )		Solid tumor
More
Phase 1
DAT-2645
 ( PARG )		Endometrial Carcinoma
More
Phase 1
DAT-1000
 ( POLQ )		Female Genital Neoplasms
More
Preclinical
DAT-5000
 ( WRN )		Solid tumor
More
Preclinical
DAT-6000
Solid tumor
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free